George W. Lloyd, EVP, Investments & GC at Royalty Pharma plc (RPRX), sold 500,000 shares at $42.33 ($21.2M) on 2021-11-16, disclosed to the SEC on 2021-11-18.
Open-market sale of $21.2M RPRX by EVP, Investments & GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.12 | 65,852 | $2.8M | 13.1% |
| 2 | $42.12 | 65,852 | $2.8M | 13.1% |
| 3 | $42.33 | 72,659 | $3.1M | 14.5% |
| 4 | $42.33 | 72,659 | $3.1M | 14.5% |
| 5 | $43.19 | 27,341 | $1.2M | 5.6% |
| 6 | $43.19 | 27,341 |
| $1.2M |
| 5.6% |
| 7 | $42.39 | 84,148 | $3.6M | 16.8% |
| 8 | $42.39 | 84,148 | $3.6M | 16.8% |
| Total | $42.39 avg | 500,000 | $21.2M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |